Akcea Therapeutics, Inc.

Doing business as Akcea Therapeutics Part of Ionis Pharmaceuticals, Inc.

UEI
REAPMHUALJ99
CAGE
897W4
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date
Website
ionis.com
Founded
1996
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Information Technology
  2. Software & Services
  3. Internet Software & Services
SIC code
73 Business Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Akcea Therapeutics, Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Inotersen 284MG/1.5ML Contract · 36C25019N0775 Veterans Integrated Service Network 10 $128,789

About Akcea Therapeutics, Inc.

Written by GovTribe AI ·

Akcea Therapeutics, Inc., doing business as Akcea Therapeutics, is a biotechnology company specializing in RNA targeted therapy. Akcea develops and delivers genetic medicines.

Akcea has provided pharmaceuticals to the Department of Veterans Affairs (VA) through prime federal contract awards. This includes a $128,788.98 firm fixed price delivery order from the VA Veterans Health Administration Veterans Integrated Service Network 10 for INOTERSEN, an injectable medication, to be delivered to a VA facility in Cincinnati, Ohio by April 2020.

Additionally, Akcea holds several federal contract Indefinite Delivery Vehicles (IDVs) to provide pharmaceuticals to the VA. This includes a $15 million Blanket Purchase Agreement for TEGSEDI under the Pharmaceuticals and Drugs schedule, with orders allowed through September 2021. Akcea also holds two Federal Supply Schedule contracts under the VA's Pharmaceuticals and Drugs schedule, allowing orders up to $250,000 and $25,000 respectively, with one expiring in September 2021 and the other which expired in July 2019.

Contract vehicles

Akcea Therapeutics, Inc. holds a place on 1 federal contract vehicle. Active vehicles first.

Quick answers

What is Akcea Therapeutics, Inc.'s UEI?

Akcea Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is REAPMHUALJ99.

What is Akcea Therapeutics, Inc.'s CAGE code?

Akcea Therapeutics, Inc.'s CAGE code is 897W4.

What is Akcea Therapeutics, Inc.'s primary NAICS code?

Akcea Therapeutics, Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).

Is Akcea Therapeutics, Inc. registered in SAM.gov?

Akcea Therapeutics, Inc.'s SAM.gov registration expired on February 21, 2020.

Who is Akcea Therapeutics, Inc.'s parent company?

Akcea Therapeutics, Inc. is part of Ionis Pharmaceuticals, Inc.

Which contract vehicles does Akcea Therapeutics, Inc. hold?

Akcea Therapeutics, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.

What is Akcea Therapeutics, Inc.'s most recent federal award?

Akcea Therapeutics, Inc.'s most recent federal contract award is Inotersen 284MG/1.5ML (36C25019N0775), from Veterans Integrated Service Network 10, on April 9, 2019.

On GovTribe

See Akcea Therapeutics, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login